Applications Published 1 August 2001

Published: 30-Apr-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Methods of screening for apoptosis-controlling agens for bone anabolic therapies and uses thereof
    The Board of Trustees of the University of Arkansas 1119251*

  • Use of melanin for inhibition of angiogenesis and macular degeneration
    The Children's Medical Centre Corp 1119252*

  • Novel TH2-specific molecules and uses thereof
    Millennium Pharmaceuticals 1119253*

  • Novel treatment for stroke management
    SmithKline Beecham 1119254*

  • Novel compsns and methods for prevention and treatment of protozoal disease
    New Ace Research Company 1119255*

  • Oral combination of lufenuron and nitenpyran against fleas
    Novartis 1119256*

  • Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
    General Mills 1119345*

  • RNA cancer vaccine and methods for its use
    John Wayne Cancer Institute 1119346*

  • Synergistic antimicrobial dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide
    Karagoezian, Hampar 1119347*

  • Enteric coated pharmaceutical formulation
    Norton Healthcare 1119348*

  • Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
    The Regents of the University of California 1119349*

  • RAR antagonists as male anti-fertility agents
    Allergan Sales 1119350*

  • Use of catechol derivatives as proteinase inhibitors
    Gruenenthal1119351*

  • A method fro the treatment of ocular oxidative stress
    The Webb-Waring Institute for Biomedical Research 1119352*

  • Compsns and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin
    KGK Synergize; United States Department of Agriculture 1119353*

  • Peripherally-active anti-pruritic opiates
    Adolor 1119354*

  • Naphthalenecarboxamides as tachykinin receptor antagonists
    AstraZeneca 1119355*

  • Radiolabelled neurokinin-1 receptor antagonists
    Merck 1119356*

  • C3A receptor ligands
    SmithKline Beecham 1119357*

  • Use of an NK-1 receptor antagonist for treating cognitive disorders
    Merck Sharp & Dohme 1119358*

  • 2-methyl-thieno-benzodiazepine formulation
    Eli Lilly 1119359*

  • Methods and compsns for increasing intestinal absorption of fats
    Biomolecular Products 1119360*

  • Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
    Magainin Pharmaceuticals 1119361*

  • Method of using tetracycline compounds to enhance interleukin-10 production
    The Research Foundation of State University of New York 1119362*

  • Carnitine and inositol phosphate-containing compsn useful as dietary supplement or drug
    Sigma-Tau Healthscience 1119363*

  • Inhibitors of phosphatidyl myo-inositol cycle
    Georgetown University 1119364*

  • Compsn and method of using tumour cells
    Thomas Jefferson University 1119365*

  • Method of using fetuin to induce apoptosis in cancer cells
    Tsai, David; Yu, Jenny 1119367*

  • Methods of modulating lipid metabolism and storage
    Biogen 1119368*

  • Vascular endothelial growth factor 3
    Human Genome Sciences 1119369*

  • Reversal of viral-induced systemic shock and respiratory distresses by blockade of the lymphotoxin beta pathway
    Biogen 1119370*

  • FLT4 (VEGFR-3) as a target for tumour imaging and anti-tumour therapy
    Ludwig Institute for Cancer Research 1119370*

  • Compsn and method for treating allergic diseases
    Schering 1119372*

  • Oxybutynin formulation and methods of use
    Situs 1119373*

  • Polyurethanes as topical skin protectants
    Bertek Pharmaceuticals 1119374*

  • Methods and adjuvants for stimulanting mucosal immunity
    The Regents of the University of California 1119375*

  • Removal of preexisting antibodies to enhance the effectiveness of a viral therapeutic agent
    Calydon 1119376*

  • Prostaglandin receptor ligands
    Merck Frost Canada 1119542*

  • N-arylkylaminotetralins as ligands for the neuropeptide Y Y5 receptor
    Ortho-McNeil Pharmaceutical 1119543*

  • Energetic nitramine-linked azoles and hydroxylammmonium salts as oxidisers, initiators and gas generators
    SRI International 1119544*

  • Carbamate-functional allyl monomers and polymers therefrom
    ARCO Chemical 1119545*

  • Process for preparing toluenesulphinates
    Eli Lilly 1119546*

  • Pyrrole-2,5-diones as GSK-3 inhibitors
    SmithKline Beecham 1119547*

  • Process for preparing 4-substituted 1H-indole-3-glyoxamines
    Eli Lilly 1119549*

  • 2-substituted heterocyclic sulphonamides
    Procter & Gamble 1119550*

  • Monomeric and dimeric heterocycles, and therapeutic uses thereof
    Georgetown University 1119553*

  • Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
    Aventis Pharma 1119557*

  • Continuous process for the production of anhydrosugar alcohols
    EI du Pont de Nemours 1119558*

  • 3-phenyl-pyrones
    Bayer 1119559*

  • 2,3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents)
    SmithKline Beecham 1119561*

  • Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents)
    SmithKline Beecham 1119563*

  • Cytotoxic alkaloids (Halitulin)
    Pharma Mar 1119565*

  • Novel heterocyclyl-methyl-substituted pyrazoles
    Bayer 1119566*

  • Quinazoline derivatives
    AstraZeneca 1119567*

  • 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
    Janssen Pharmaceutica 1119568*

  • Bipyridine manganese complexes
    Eukarion 1119573*

  • Substituted isophosphindolines and their use
    Aventis Research &

    Technologies 1119574*

  • Improved process for oligonucleotide synthesis
    Isis Pharmaceuticals 1119578*

  • Antisense modulation of expression of tumour necrosis receptor-associated factors (TRAFS)
    Isis Pharmaceuticals 1119580*

  • Methods of inhibiting smooth muscle cell proliferation and preventing restenosis with a vector expressing RB2/P130
    Thomas Jefferson University 1119581*
    See more

    • You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    Read more
    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

    Trending Articles

    1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
    2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
    3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
    4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
    5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
    Manufacturing

    Sapio Sciences introduces world’s first 3rd-generation ELN

    Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
    Manufacturing

    Signal Group launches MCERTS approved VOC emissions monitor

    New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
    Research & Development

    Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

    The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
    You need to be a subscriber to read this article.
    Click here to find out more.
    Packaging

    Cloud labelling and serialisation: the new frontline of traceability in drug delivery

    As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
    Manufacturing

    Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

    The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
    Manufacturing

    L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

    Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
    Subscribe now